Ex. TP53, BRCA, T790M, or another? As of now, T790M mutation is one of the few de novo mutations found in treatment naïve patients that have been...
New answer by Medical Oncologist at The University of Chicago (March 6, 2023)
In light of the data presented by Dr. @Renato Martins at the ASCO Plenary series in August 2022, I have increased my referrals for germline mutation testing in lung cancer pat...